Purchase Order SPE2DS21V6349
Award Date
6/10/21
Potential Completion Date
6/17/21
Potential Value
$5.9K
Federal Agency
Medical Supply Chain
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
621410 - Family Planning Centers
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Eno Valley, NC 27712, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government awarded a firm-fixed-price purchase order contract to Biomerieux Inc., through its Biomerieux, Inc. Division, for the supply of blood collection products. The contract has a ceiling value of $3,640.02 and an ultimate completion date of August 9, 2024. It was awarded on July 26, 2024 by the Medical Supply Chain, a component of the Defense Logistics Agency. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics,...
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
This firm-fixed-price delivery order was awarded by a U.S. government agency to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of its proprietary BioMerieux products. The $56,200 contract is for BioMerieux's specialized clinical diagnostic equipment, reagents, and supplies, including automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. The award was made under Biomerieux's Federal Supply...
This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This federal contract award, valued at $208,563.04, was made by the U.S. Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for a Microbial Identification and Susceptibility Testing Service Agreement, which provides the VA with Biomerieux's proprietary diagnostic platforms, reagents, test kits, and maintenance services. This purchase order has a firm fixed price and an ultimate completion date of September 30, 2024. The contract is...
This federal contract award, identified as SPE2DS22P2217, was issued by the Medical Supply Chain division of the Defense agency to Biomerieux Inc., a global leader in in vitro diagnostics. The $5,890.00 firm-fixed-price purchase order is for the delivery of blood collection supplies. The contract has no set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, is the prime contractor and manufacturer of the requested products. The award is part of Biomerieux's existing...
This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of automated blood culture testing products and services. The $102,354 firm-fixed-price contract was awarded by the Veterans Integrated Service Network 6, which is part of the U.S. Department of Veterans Affairs, a civilian agency. The contract has an ultimate completion date of June 3, 2025 and does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division,...
This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, is for the supply of the company's proprietary diagnostic platforms, reagents, test kits, and maintenance services to various government healthcare operations. The contract has a ceiling value of $30,228 and is a firm fixed-price purchase order with a completion date of May 31, 2026. The award was issued by the Office of Logistics and Acquisition Operations, a civilian agency. Biomerieux Inc. has been...